SINGULAIR - On March 27, 2008, the FDA informed health care professionals and patients of possible connections between the use of Singulair and behavioral or mood changes.  It is believed Singulair increases the risk of suicide and suicidal behavior.  Patients on Singulair should be monitored closely by their treating physicians in order to hopefully catch any negative side effects before the patient does serious harm to themselves or others.  

Singulair is Merck's (NYSE: MRK) top-selling asthma drug, but its sales have slowed recently over these safety concerns.

If you have experienced any suicidal thoughts or noticed that a loved one is suddenly acting differently, and you or that loved one is taking Singulair, the mood change may very well be caused by Singulair.

You or your loved one may be entitled to compensation if Singulair is found to be the reason for the complications and the injuries that resulted.

Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of taking Singulair, please fill out the form below for a free evaluation.
 
Keywords: Singulair Lawsuit | Singulair Attorneys | Singulair Lawyers | Singulair Attorney | Singulair Lawyer